Loa loa loiasis was considered an anecdotal disease 30 years ago. Its spread in Equatorial
Africa and the side effects associated with mass drug administration programs against …

Loa loa, the African eye worm, is a filarial pathogen transmitted by blood-sucking flies of the
genus Chrysops. Loiasis primarily affects rural populations residing in the forest and …

Background Loiasis–a filarial disease endemic in Central and West Africa–is increasingly
recognized as significant individual and public health concern. While the understanding of …

Abstract Background Loiasis (Loa loa filariasis) is considered a benign disease and is
currently not included in the World Health Organization's (WHO's) list of Neglected Tropical …

Background A test-and-not-treat (TaNT) strategy has been developed to prevent people with
high concentrations of circulating Loa loa microfilariae (> 20 000 microfilariae per mL) …

Background Loa loa filariasis (loiasis) is still considered a relatively benign disease.
However, recent epidemiologic data suggest increased mortality and morbidity in L. loa …

Loiasis, caused by the filarial nematode Loa loa, is endemic in Central and West Africa. Loa
loa has been associated with severe adverse reactions in high Loa-infected individuals …

Background After ivermectin became available, diethylcarbamazine (DEC) use was
discontinued because of severe adverse reactions, including ocular reactions, in individuals …

Background Loiasis is one of the significant filarial diseases for people living in West and
Central Africa with wide endemic area but is not seen in China. As economy booms and …

Background Endemic to Central Africa, loiasis, caused by the vector-borne worm Loa loa,
affects approximately 10 million individuals. Clinical manifestations include transient …